WHO target product profiles for COVID-19 therapeutics

Overview

WHO is here publishing Draft Target Product Profiles (TPP) for treatment of COVID-19 in hospitalized patients. These TPPs describes the preferred and minimally acceptable profiles for therapeutic agents for the treatment of those hospitalized with  COVID-19, ranging from mild through moderate to severe to critically ill patients in three sets of TPPs.  We welcome comments on the document. Please send them to salamik@who.int  by the 14^th of August 2020. Please use the comment form provided. All forms should be completed with the details of the individual or organization providing the comment.